Klinisk Biokemi i Norden · 3 2015
| 39
human sperm progressive motility by prosta-
somes. Urol Res 1982;10(5):253-7.
5. Ronquist G, Brody I. The prostasome: its secre-
tion and function in man. Biochim Biophys
Acta 1985;822:203-18.
6. Fabiani R, Johansson L, Lundkvist O, Ronquist
G. Enhanced recruitment of motile sperma-
tozoa by prostasome inclusion in swim-up
medium. Hum Reprod 1994;9:1485-9.
7. Ronquist G, Nilsson BO, Hjerten S. Interaction
between prostasomes and spermatozoa from
human semen. Arch Androl 1990;24:147-57.
8. Arvidson G, Ronquist G, Wikander G, Ojteg
AC. Human prostasome membranes exhibit
very high cholesterol/phospholipid ratios yiel-
ding high molecular ordering. Biochim Biophys
Acta 1989;984:167-73.
9. Olsson I, Ronquist G. Nucleic acid association to
human prostasomes. Arch Androl 1990;24:1-10.
10. Pan BT, Johnstone RM. Fate of the transferrin
receptor during maturation of sheep reticulo-
cytes in vitro: selective externalization of the
receptor. Cell 1983;33:967-78.
11. Harding C, Heuser J, Stahl P. Receptor-media-
ted endocytosis of transferrin and recycling of
the transferrin receptor in rat reticulocytes. J
Cell Biol 1983;97:329-39.
12. Johnstone RM, Adam M, Hammond JR, Orr
L, Turbide C. Vesicle formation during reti-
culocyte maturation. Association of plasma
membrane activities with released vesicles
(exosomes). J Biol Chem 1987;262:9412-20.
13. Raposo G, Nijman HW, Stoorvogel W, Lie-
jendekker R, Harding CV, Melief CJ, et al. B
lymphocytes secrete antigen-presenting vesic-
les. J Exp Med 1996;183:1161-72.
14. Thery C, Ostrowski M, Segura E. Membrane
vesicles as conveyors of immune responses.
Nature Rev Immunol 2009;9:581-93.
15. Ratajczak J, Miekus K, Kucia M, Zhang J, Reca
R, Dvorak P, et al. Embryonic stem cellderi-
ved microvesicles reprogram hematopoietic
progenitors: evidence for horizontal transfer
of mRNA and protein delivery. Leukemia
2006;20:847-56.
16. Valadi H, Ekström K, Bossios A, Sjöstrand M,
Lee JJ, Lötvall JO. Exosome-mediated transfer
of mRNAs and microRNAs is a novel mecha-
nism of genetic exchange between cells. Nature
Cell Biol 2007;9:654-9.
17. Melo SA, Sugimoto H, O’Connell JT, Kato N,
Villanueva A, Vidal A, et al. Cancer exosomes
perform cell-independent microRNA biogene-
sis and promote tumorigenesis. Cancer Cell
2014;26:707-21.
18. Carlsson L, Lennartsson L, Nilsson BO, Nils-
son S, Ronquist G. Growth-inhibitory effect
of prostasomes on prostatic cancer cell lines
in culture. Eur Urol 2000;38:468-74.
19. Logozzi M, De Milito A, Lugini L, Borghi M,
Calabro L, Spada M, et al. High levels of exoso-
mes expressing CD63 and caveolin-1 in plasma
of melanoma patients. PloS One 2009;4:e5219.
20. Yoshioka Y, Konishi Y, Kosaka N, Katsuda
T, Kato T, Ochiya T. Comparative marker
analysis of extracellular vesicles in different
human cancer types. J Extracell Vesicles
2013;2:1-9.
21. Welker MW, Reichert D, Susser S, Sarrazin C,
Martinez Y, Herrmann E, et al. Soluble serum
CD81 is elevated in patients with chronic hepa-
titis C and correlates with alanine aminotrans-
ferase serum activity. PloS One 2012;7:e30796.
22. Tavoosidana G, Ronquist G, Darmanis S, Yan
J, Carlsson L, Wu D, et al. Multiple recognition
assay reveals prostasomes as promising plasma
biomarkers for prostate cancer. Proc Natl Acad
Sci USA. 2011;108:8809-14.
23. Taylor DD, Gercel-Taylor C. MicroRNA signa-
tures of tumor-derived exosomes as diagnostic
biomarkers of ovarian cancer. Gynecol Oncol
2008;110:13-21.
24. Rabinowits G, Gercel-Taylor C, Day JM, Taylor
DD, Kloecker GH. Exosomal microRNA: a
diagnostic marker for lung cancer. Clin Lung
Cancer 2009;10:42-6.
25. TanakaY, KamoharaH, KinoshitaK, Kurashige
J, Ishimoto T, Iwatsuki M, et al. Clinical
impact of serum exosomal microRNA-21 as a
clinical biomarker in human esophageal squa-
mous cell carcinoma. Cancer 2013;119:1159-67.
26. Ronquist G. Prostasomes are mediators of
intercellular communication: from basic
research to clinical implications. J Int Med
2012;271:400-13.
